Table 36.
Country | Resistance to ciprofloxacin, erythromycin and tetracycline | |
---|---|---|
N | % Res | |
Austria | 37 | 2.7 |
Cyprus | 7 | NA |
Estonia | 19 | 57.9 |
Finlanda | 143 | 33.6 |
Franceb | 850 | 5.1 |
Italy | 11 | 27.3 |
Lithuaniab | 40 | 12.5 |
Luxembourg | 53 | 13.2 |
Malta | 7 | NA |
Netherlandsb | 99 | 6.1 |
Portugal | 34 | 47.1 |
Romania | 16 | 0.0 |
Slovakiab | 41 | 0.0 |
Slovenia | 130 | 1.5 |
Spain | 38 | 21.1 |
United Kingdom | 325 | 4.6 |
Total (16 MSs) | 1,850 | 9.2 |
Norway | 10 | 10.0 |
N: number of isolates tested; NA: not applicable; % Res: percentage of resistant isolates.
Travel‐associated cases, accounting for 65% of Campylobacter infections in Finland in 2016, could not be excluded from the Finnish AST data.
Data interpreted with clinical breakpoints.